Innovative implant from Nvision corrects hammertoe, and expands product offering to lower extremities
San Antonio, TX (US) / Thornton Cleveleys (UK), March 11, 2019 – The Vector™ Hammertoe Correction System, a bioimplant from Nvision Biomedical Technologies, a medical device and biologics company, has been cleared by the FDA for use in the US. It is the first foot and ankle implant to be made from the advanced, biocompatible PEEK-OPTIMA™ HA Enhanced, a polymer from Invibio Biomaterial Solutions™.
Published in News

Nvision Biomedical Technologies, a San Antonio-based medical device and biologics manufacturer, has received clearance from the U.S. Food and Drug Administration (FDA) for its focus® Pedicle Screw System.

Published in News